Skip to main content
Equibles

INMD · InMode Ltd. · Metrics

Track INMD — free

Use INMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$13.58 -0.14 (-1.02%) At close · Oct 27 Q1 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$781.45M
Shares
57.54M
Volume · Oct 27 451.59K Avg daily vol (3M) 477.78K

INMD metrics

57 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$13.58
Market cap
$781.45M

Price action

20 metrics
Price change (1W)
-4.0%
Price change (30D)
-4.4%
Price change (3M)
-12.2%
Price change (6M)
-4.4%
Price change (YTD)
-7.6%
Price change (1Y)
-13.2%
Trailing year
Price change (5Y)
-83.6%
52-week high
$16.62
52-week low
$12.76
Change from 52-week high
-18.3%
Change from 52-week low
+6.4%
Annualized volatility
30.0%
Annualized volatility (3M)
12.0%
Beta
0.6
RSI (14D)
25.6
Price vs SMA 50
-6.2%
Price vs SMA 200
-5.3%
Avg volume (3M)
477,777
Relative volume
1.0
Average dollar volume
$7.00M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
57.54M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.2
reciprocal yield 86.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-06

Profitability

9 metrics
Gross margin
78.5%
Operating margin
23.0%
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$10.78

Growth

11 metrics
Revenue growth YoY
+10.6%
Year over year
Net income growth YoY
+22.5%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+50.0%
Shares change YoY
-18.8%
Year over year · fewer shares
Revenue CAGR (3Y)
-6.6%
Revenue CAGR (5Y)
+12.4%
EPS CAGR (3Y)
-8.9%
EPS CAGR (5Y)
+9.9%
FCF CAGR (3Y)
-22.3%
FCF CAGR (5Y)
+1.4%

Quality

14 metrics
Return on equity
25.1%
Return on assets
22.9%
Debt / equity
—
Current ratio
9.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
8.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$302.54M
Total assets
$766.43M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
190
13F filer change QoQ
-4
Institutional ownership
57.0%
Conviction holders (share of 13F filers)
1.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-5.5%
Holder tenure
12.9
Price vs estimated holder cost
-8.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.0%

Short interest

3 metrics
Short interest
3.9%
Latest settlement · 4.8 days to cover
Days to cover
4.8d
Short-squeeze score
54 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1742692 CUSIP M5425M103 13F (30d) 27 filings 27 filers Visit website Investor relations